Bioactive prenylated coumarins as potential anti-inflammatory and anti-HIV agents from Clausena lenis. 2020

Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, Hainan Normal University, Haikou 571158, PR China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China; Key Laboratory of Tropical Medicinal Plant Chemistry of Hainan Province, Hainan Normal University, Haikou 571158, PR China.

The phytochemical study on the stems of Clausena lenis resulted in the isolation of three new prenylated coumarins, clauselenins A-C (1-3), together with nine known prenylated coumarins (4-12). The chemical structures of new prenylated coumarins (1-3) were elucidated by means of comprehensive spectral analyses and the known compounds (4-12) were determined by means of comparing their experimental spectral data with those described data in the literatures. All isolated prenylated coumarins were assessed for their anti-inflammatory effects together with anti-HIV activities in vitro. Prenylated coumarins 1-12 displayed remarkable inhibitory effects against nitric oxide (NO) production induced by lipopolysaccharide in mouse macrophage RAW 264.7 cells in vitro with the IC50 values which are comparable to hydrocortisone. Meanwhile, prenylated coumarins 1-12 exhibited considerable anti-HIV-1 reverse transcriptase (RT) activities possessing EC50 values in the range of 0.17-9.08 µM. These findings indicate that the isolation and identification of these prenylated coumarins with pronounced anti-inflammatory effects as well as anti-HIV activities separated from the stems of C. lenis could be of great significance to the development of new anti-inflammatory and anti-HIV agents and their potential applications in the pharmaceutical industry.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse

Related Publications

Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
March 2022, Molecules (Basel, Switzerland),
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
May 2022, Natural product research,
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
September 2019, Natural product research,
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
October 2019, Bioorganic chemistry,
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
September 2016, Chemistry & biodiversity,
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
October 2016, Natural products and bioprospecting,
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
December 2021, The Journal of organic chemistry,
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
March 2003, European journal of medicinal chemistry,
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
November 2021, Planta medica,
Yan-Ping Liu, and Gui Yan, and Yu-Tong Xie, and Tian-Ci Lin, and Wei Zhang, and Juan Li, and Ying-Ju Wu, and Jun-Yu Zhou, and Yan-Hui Fu
October 2017, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!